Cosmo Pharmaceuticals N.V. (FRA:C43)

Germany flag Germany · Delayed Price · Currency is EUR
70.00
-1.00 (-1.41%)
At close: Oct 17, 2025
-1.41%
Market Cap1.19B
Revenue (ttm)182.27M
Net Income (ttm)59.99M
Shares Outn/a
EPS (ttm)3.67
PE Ratio19.84
Forward PE34.01
Dividend2.05 (2.93%)
Ex-Dividend DateJun 4, 2025
Volume100
Average Volume141
Open70.00
Previous Close71.00
Day's Range70.00 - 70.00
52-Week Range47.80 - 79.00
Betan/a
RSI52.51
Earnings DateOct 23, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 322
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C43
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.